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Abstract
In Plasmodium falciparum malaria, activation of monocytes and macrophages (monocytes/macrophages) can result in the
production of various inflammatory mediators that contribute to immunopathology. Soluble CD163 (sCD163) is a specific
marker of monocyte/macrophage activation typically found at increased levels during various inflammatory conditions and
can be associated with poor clinical outcomes. To better understand the relationships between levels of sCD163 and clinical
parameters in women with placental malaria, we measured plasma sCD163 levels in maternal peripheral and placental
blood compartments at delivery and determined their correlations with birth weight and maternal haemoglobin
concentrations. sCD163 levels were negatively correlated with birth weight only in the placental compartment (r =20.145,
p = 0.03) and were inversely correlated with maternal haemoglobin concentrations, both in peripheral blood (r =20.238,
p = 0.0004) and in placental blood (r =20.259, p = 0.0001). These inverse relationships suggest a potential role for
monocyte/macrophage activation in the pathogenesis of malaria in pregnancy, particularly in relation to malaria-associated
anaemia.
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Introduction
Malaria infection during pregnancy can be associated with
maternal anaemia and low birth weight, which leads to significant
disease burden in many populations [1]. A common manifestation
of malaria in pregnancy is the sequestration of Plasmodium
falciparum-infected erythrocytes in placental intervillous blood
spaces, a defining feature of placental malaria (PM). PM can
initiate a local inflammation (intervillositis or IV), characterised by
the accumulation of mononuclear phagocytes (monocytes/macro-
phages) in placental intervillous blood spaces. Increased numbers
of monocytes/macrophages in malaria-infected placentas have
been associated with higher prevalence and significantly elevated
risk of maternal anaemia and low birth weight [2–4]. The latter
may be due to a role of PM-associated IV in foetal growth
restriction, in which it has been linked to reduced maternal and
fetal blood levels of insulin-like growth factor-I [5] and to
dysregulated amino acid transport across the placenta [6].
Soluble mediators associated with monocyte/macrophage
activation are commonly found at increased levels in malaria-
infected pregnant women [7,8]. High levels of placental interferon-
c, a potent activator of monocytes/macrophages, were associated
with low birth weight in Kenyan women [9] but not in a Malawian
cohort [10]. Macrophage migration inhibitory factor, which helps
to sustain macrophage activation and is implicated in the
pathogenesis of anaemia [11], was increased in the placental
intervillous blood of women with PM [12]. Monocytes/macro-
phages constitute a major source of tumor necrosis factor-a, high
levels of which in placental blood were associated with severe
maternal anaemia [9] and low birth weight [9,10]. Collectively,
these studies suggest that increased monocyte/macrophage
activation may contribute to the pathogenesis of PM-associated
maternal anaemia and low birth weight.
Soluble CD163 (sCD163) is a novel marker of monocyte/
macrophage activation. It is derived from the cleavage of
membrane-bound CD163, a monocyte/macrophage receptor
involved in scavenging haptoglobin-haemoglobin complexes
[13]. Shedding of membrane-bound CD163 is a physiological
process, with detectable levels found in normal healthy individuals
[14]. In the presence of infection or inflammation associated with
monocyte/macrophage activation, this shedding process can be
significantly enhanced [15]. High blood levels of sCD163 have
been reported in various inflammatory conditions including
rheumatoid arthritis [16], coronary atherosclerosis [17] and sepsis
[18]. Increased sCD163 levels are often associated with poor
clinical outcomes [19,20]. The relationship between malaria
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infection and sCD163 is unclear: one study found elevated
sCD163 levels in children with uncomplicated malaria compared
to severe malaria [21], while in another study where most patients
had P. vivax infections, sCD163 levels were higher in patients with
symptomatic malaria than in uninfected or asymptomatic patients
[22].
To better understand the relationship between sCD163 levels
and PM pathogenesis, we investigated whether increased sCD163
levels in maternal systemic circulation and in the placenta,
correlated with clinical outcomes in PM. We found elevated
sCD163 levels in the placental compartment of women with PM
and IV compared to uninfected women or to women with PM
without IV. There was a weak inverse correlation between
placental sCD163 levels and birth weight, while sCD163 levels in
both maternal and placental blood negatively correlated with
maternal haemoglobin concentrations.
Materials and Methods
Ethics Statement
Ethics approval for this study was granted by the College of
Medicine Research Committee, University of Malawi and the
Melbourne Health Human Research Ethics Committee. Written
informed consent was obtained from all participating women.
Study Samples
Plasma samples were obtained from a previously described
cohort [23]. Briefly, participants were pregnant women who
attended the Gogo Chatinkha Banda Maternity Unit at the Queen
Elizabeth Central Hospital in Blantyre, Malawi from 2001–2006.
At delivery, the placenta was cut at the maternal side and blood
welling into the incision was collected. Placental and peripheral
bloods were both collected into citrate-coated tubes and plasma
samples were stored at 280uC. Demographic and obstetric
information, including maternal haemoglobin levels at delivery
and birth weight, were recorded. Placental villous tissue biopsies
fixed in 10% neutral-buffered formalin and embedded in paraffin
were used for histologic assessment for malaria as previously
described [4].
Participant Selection Criteria and Malaria Diagnosis
Women in their first and second pregnancies are most
susceptible to PM and the associated poor outcomes [24].
Therefore, all primi- and secundigravidae whose paired peripheral
and placental plasma samples were available were selected for the
current study. Women were categorised into uninfected, PM
without IV and PM with IV based on placental histology, as
previously described in [4]. Briefly, women with detectable
Plasmodium falciparum-infected erythrocytes in the placental inter-
villous blood spaces, in the absence of monocyte accumulation
(,5% of all intervillous cells), were classified under ‘‘PM without
IV’’ group. Participants with both infected erythrocytes and $5%
monocyte count in the intervillous blood spaces were classified
under the ‘‘PM with IV’’ group. Uninfected women had
undetectable parasitaemia in both peripheral blood smear and
placental histology sections; these women also did not have
monocyte accumulation in the placenta.
Quantification of sCD163 Levels
Plasma concentrations of sCD163 were measured using a
commercial ELISA kit (R&D Systems) according to the manufac-
turer’s instructions. Capture antibodies prepared at 2 mg/mL were
used to coat 96-well plates (Nunc) overnight (100 mL per well). The
plates were then washed three times in PBS-Tween20 (0.05%) and
blocked with 300 mL reagent diluent (1% BSA in PBS) for an
hour. Plasma samples were spun at 1,0006g, 4uC for 15 minutes
to pellet debris. Most supernatants were then diluted 1:100 in
reagent diluent; a few samples were diluted up to 1:500 so that the
resultant concentration fell within the range of the standard curve.
Standards for sCD163 were prepared by 1:1 serial dilution,
resulting in a 7-point standard curve ranging from 10,000 pg/mL
to 156.25 pg/mL. Each sample or standard was added in
duplicate after the blocking step and incubated for 2 hours. The
plates were washed three times in PBS-Tween20 (0.05%) and
Table 1. Participants’ characteristics.
Uninfected PM without IV PM with IV p-value
n 84 147 70 N/A
Maternal age (years) 19 (18, 21) 19 (18, 21) 18.5 (17, 20)a 0.03
Gravidity 1 (1, 2) 1 (1, 1) 1 (1, 1) 0.1
Gestational age (weeks) 38 (37, 40) 39 (38–40) 38 (38, 40) 0.09
Haemoglobin concentration (g/dL ) 11.961.8 12.161.9 10.962.2b 0.0002
Birth weight (kg) 2.9460.4 2.9160.4 2.8260.4 0.2
Number of anaemic cases 24 (28.5%) 40 (27%) 37 (52.8%) 0.0005
Number of low birth weight cases 12 (14%) 17 (11.5%) 14 (20%) 0.2
Monocytes on placental histology (%) 0 (0, 0) 2.2 (1.2, 3) 8.6 (6.3, 12.9) ,0.0001c
Parasitised erythrocytes on placental histology (%) 0 (0, 0) 0.6 (0.2, 2) 4 (0.6, 17.9) ,0.0001d
Participants were grouped into uninfected women or women with placental malaria (PM), with or without intervillositis (IV), and their characteristics were compared.
Data are represented as median (25th, 75th percentiles), except for haemoglobin concentration and birth weight (mean 6 standard deviation), as well as the number of
anaemic and low birth weight cases. The percentages of parasitised erythrocytes and monocytes were determined from 500 cells counted in placental intervillous
spaces. All parameters were recorded at delivery. Differences between proportions of anaemic and low birth weight cases were tested using chi-square test.
Comparisons for normally distributed and non-normally distributed variables were performed using one-way ANOVA and Kruskal-Wallis test, respectively. When p-value
is ,0.05, either a post Tukey’s or Dunn’s multiple comparison test was performed and differences that remained significant are as follows:
ap,0.05 for PM with IV group versus uninfected.
bp,0.01 for PM with IV group versus uninfected and p,0.001 for PM with IV group versus PM without IV group.
c, dp,0.001 for uninfected versus both PM and PM with IV groups, and for PM versus PM with IV group.
doi:10.1371/journal.pone.0064127.t001
sCD163 in Placental Malaria
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detection antibody was added for 2 hours (1 mg/mL; 100 mL per
well). After three washes in PBS-Tween20 (0.05%), horseradish
peroxidase was added for 20 minutes (100 mL per well). After a
final series of washes (thrice in PBS-Tween20 (0.05%)), horserad-
ish peroxidase substrate solution (BD Biosciences) was added for
20 minutes. The colorimetric reaction was then stopped by the
addition of 2N H2SO4 (50 mL per well). Optical density was read
at 450 nm with a 550 nm reference wavelength using a microplate
reader (Bio-Rad). All incubations were done at room temperature.
Statistical Analysis
Data were analysed in GraphPad Prism (Version 5.0). The
distribution of data was analysed for normality using Shapiro-Wilk
test. For non-normally distributed variables, 2-group comparison
was performed using Mann-Whitney test. When comparing three
groups or more, Kruskal-Wallis test was used and whenever p-
value was less than 0.05, a post Dunn’s multiple comparison test
was performed. For normally-distributed variables, t-test was used
for comparison across two groups, while one-way ANOVA was
used for comparing three groups or more. For the latter, a Tukey’s
multiple comparison test was performed whenever p-value was less
than 0.05. Chi-square test was used to test the difference in the
proportions of women with anaemia or low birth weight between
all groups. Pearson’s correlation test was used to identify potential
correlations between the levels of sCD163 and clinical parameters.
In the figures, p-value of less than 0.05 is denoted with *, p,0.01
with ** and p,0.001 with ***.
Results
Clinical Characteristics of Study Cohort
Clinical characteristics of the 301 participating women recorded
at delivery are summarised in Table 1. Maternal age, haemoglobin
levels, parasitaemia and monocyte density were significantly
different across groups. Maternal age was significantly lower in
the PM with IV group compared to uninfected women (p,0.05).
Maternal haemoglobin levels were also significantly lower in the
PM with IV group, compared to uninfected women (p,0.01) and
PM without IV group (p,0.001). Other parameters including
gravidity, gestational age and birth weight did not differ amongst
the different groups. The proportion of anaemic women (haemo-
globin level ,11 g/dL) in each group was significantly different
(p = 0.0005), but the proportion of women who delivered low birth
weight babies (,2,500 g at time of delivery) was similar across
groups (p = 0.2).
Increased Levels of Placental sCD163 in Women with
Placental Malaria with Intervillositis
There was no statistically significant difference in the levels of
sCD163 in maternal peripheral blood across groups (p = 0.1)
(Figure 1A): [median (25th, 75th percentile)] 576.2 ng/mL (417.7,
821.1) for uninfected women, 552.6 ng/mL (400.2, 832.1) for
women in the PM without IV group and 705.4 ng/mL (503.5,
900.6) for women in the PM with IV group. In contrast, sCD163
placental blood levels varied significantly across groups
(p = 0.0049): the levels were significantly higher in the PM with
IV group compared to uninfected women (p,0.01) and women in
the PM without IV group (p,0.05) (Figure 1B). For all women
with PM (with and without IV), monocyte numbers in the
intervillous blood spaces were positively correlated with sCD163
levels in the placental blood (r = 0.19, p = 0.003) (Figure 1C).
Figure 1. sCD163 levels in peripheral and placental blood.
Women were classified into uninfected, placental malaria without
intervillositis (PM without IV) or PM with IV groups. (A) sCD163 levels in
peripheral blood did not differ between the groups (p = 0.1). (B) Women
in the PM with IV group had significantly higher sCD163 placental blood
levels compared to uninfected women and women in the PM without
IV group (* p,0.05 and ** p,0.01). (C) Monocyte counts in the placenta
were positively correlated with sCD163 levels in the placental blood
(r = 0.19, p = 0.003).
doi:10.1371/journal.pone.0064127.g001
sCD163 in Placental Malaria
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Placental sCD163 Levels and Birth Weight are Negatively
Correlated
To investigate if clinical outcomes were associated with
peripheral or placental blood sCD163 levels, infected women
were first grouped into those with sCD163 levels higher (high
sCD163) or lower (low sCD163) than median levels for each blood
compartment. There was no significant difference in birth weight
when women were grouped into high or low sCD163, based either
on peripheral (p = 0.5) (Figure 2A) or placental blood levels
(p = 0.1) (Figure 2B). In addition, peripheral blood sCD163 levels
did not correlate with birth weight (p = 0.8) (Figure 2C), but
placental sCD163 levels showed a negative correlation with birth
weight (r =20.145, p= 0.03) (Figure 2D). When similar correla-
tion analysis was performed on uninfected women, there was no
statistically significant relationship between sCD163 and birth
weight in the peripheral (p = 0.6) and placental blood (p = 0.7).
sCD163 and Maternal Haemoglobin Levels are Inversely
Correlated
Maternal haemoglobin levels were compared between infected
women with low and high sCD163 levels (Figure 3). Women with
low sCD163 levels in peripheral blood had significantly higher
haemoglobin levels (mean 6 standard deviation: 12.261.9 g/dL)
compared to women with high sCD163 levels in peripheral blood
(11.362.1 g/dL) (p = 0.001; Figure 3A). Similarly, women with
low sCD163 in placental blood had higher haemoglobin levels
(12.162.0 g/dL) than women with high sCD163 levels in
placental blood (11.362.1 g/dL) (p = 0.009; Figure 3B). Maternal
haemoglobin levels were negatively correlated with sCD163 levels
in both the peripheral (r =20.238, p = 0.0004; Figure 3C) and
placental blood (r =20.259, p = 0.0001; Figure 3D). In uninfected
women, there was a negative correlation between haemoglobin
levels and sCD163 levels in peripheral blood (r =20.319,
p = 0.003), while no statistically significant correlation was
observed in the placental blood compartment (p = 0.4). When
infected women were grouped into anaemic (,11 g/dL) and non-
anaemic ($11 g/dL) groups, sCD163 levels in both the peripheral
(p = 0.007) and placental blood (p = 0.0006) were higher in
anaemic women compared to non-anaemic women. sCD163
levels however were not statistically different between anaemic and
non-anaemic uninfected women: peripheral blood (p = 0.1) and
placental blood (p= 0.2).
Figure 2. Relationship between sCD163 levels and birth weight. Women with placental malaria were categorized into those with sCD163
levels lower or higher than median levels for each compartment and birth weight was compared across the two groups. (A) Birth weight did not
differ between women who had high or low levels of sCD163 either in their peripheral blood (p = 0.5) or (B) in their placental blood (p = 0.1). (C) Birth
weight was not correlated with peripheral blood sCD163 levels (p = 0.8) but negatively correlated with (D) placental blood sCD163 levels (r =20.145,
p = 0.03).
doi:10.1371/journal.pone.0064127.g002
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Discussion
Monocyte accumulation in placental blood intervillous spaces
during PM is associated with poor clinical outcomes [2–4]. In this
study, we investigated the relationship between monocyte/
macrophage activation, marked by increased sCD163 levels, and
clinical outcomes in PM. In a cohort of uninfected women and
women with PM, with or without IV, we first compared sCD163
levels by participant group in maternal peripheral and placental
blood. We did not observe any differences in the sCD163 levels in
maternal peripheral blood across the groups. It was previously
reported that maternal peripheral blood monocytes are present in
a constant activation state throughout gestation in normal
pregnancies [25]. This monocyte activation may have resulted in
high peripheral baseline levels of sCD163 in uninfected pregnant
women, and reduced a potential difference in sCD163 levels
between uninfected women and women with PM, with or without
IV. In this connection, it was previously reported that sCD163
levels were elevated in maternal peripheral blood during the first
trimester of normal pregnancies [26].
Differences in placental blood levels of sCD163 across the three
groups of women were observed. In a previous study, higher
sCD163 placental blood levels were detected in women with PM
(detected by microscopy) than in uninfected women; that study did
not differentiate women with or without IV [27]. In our study,
when we separately grouped women with PM into those with or
without IV, placental sCD163 was only elevated in women with
both PM and IV. We propose that the higher placental sCD163
levels in women with PM and IV can be attributed to both
increased monocyte activation and higher number of monocyte
counts in their placental intervillous blood spaces. In support of the
latter, we found a positive correlation between monocyte numbers
in the intervillous blood spaces and sCD163 placental blood levels
in infected women.
CD163 is only highly expressed by the classical and interme-
diate subsets of monocytes [28], suggesting that the high placental
blood levels of sCD163 in women with PM and IV could be
attributed to selective recruitment and retention of these monocyte
subsets in infected placentas. This hypothesis could be further
explored by immuno-phenotyping placental monocytes/macro-
phages.
Figure 3. Relationship between sCD163 levels and maternal haemoglobin levels. Women with placental malaria were categorized into
those with sCD163 levels lower or higher than median levels for each compartment and maternal haemoglobin levels were compared across the two
groups. (A) Women with high peripheral sCD163 levels had significantly lower haemoglobin levels compared to women with low peripheral sCD163
(p = 0.001). (B) A similar relationship was observed for the placental compartment (p = 0.009). Maternal haemoglobin levels correlated negatively with
sCD163 levels, (C) in the peripheral blood (r =20.238, p = 0.0004) and (D) in the placental blood (r =20.259, p = 0.0001).
doi:10.1371/journal.pone.0064127.g003
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Monocyte/macrophage activation during malaria infection
leads to the production of TNF-a, which at high levels has been
repeatedly associated with low birth weight [4,9]. Although
sCD163 levels correlate positively with TNF-a levels [21], we
did not find any association between peripheral sCD163 levels and
birth weight. There was however, a weak negative correlation
between placental blood sCD163 levels and birth weight. Because
the biological function of sCD163 is still unclear and we did not
measure TNF-a in this study, we cannot ascertain if high sCD163
levels has a direct pathogenetic link to poor birth outcomes or that
the inverse correlation is indirectly linked to increased TNF-a
levels in the placenta.
In various disease conditions, increased sCD163 levels are
usually markers of strong and dysregulated innate immune
responses associated with poor clinical outcomes [15]. In malaria,
the findings are less conclusive with a study reporting higher
sCD163 levels in symptomatic P. vivax malaria patients than in
asymptomatic or uninfected patients [22], while another study
found elevated sCD163 levels in children with uncomplicated
malaria compared to those with severe malaria [21]. Increased
shedding of CD163 is attributed to monocyte/macrophage
activation during inflammation [15], but the resulting sCD163
may have anti-inflammatory properties [15]. Thus, in the latter
study, it was hypothesized that malaria patients with higher levels
of sCD163 were able to down-regulate inflammation and
consequently were protected against severe disease [21]. In the
present study, we found higher sCD163 levels in women with PM
and IV (the group usually at highest risk of PM-associated
outcomes) and in anaemic women. In addition, sCD163 levels
were negatively correlated with maternal haemoglobin levels and
birth weight. Therefore, our observations suggest that high
sCD163 levels are not associated with protection in PM and are
more consistent with immune activation rather than down-
regulation.
There are several limitations to the current study. Because this
was a retrospective study and the women had not been screened
for other infectious diseases apart from malaria, we could not rule
out this potentially confounding factor. Participant selection based
on the availability of paired peripheral and placental blood
samples may have introduced selection bias, particularly in the PM
with IV group. We propose this because both birth weight and the
prevalence of low birth weight were not different in the PM with
IV cases compared to the other two groups, unlike previous studies
[2,4]. It is possible that the participants in the PM with IV group in
this study may not fully represent the actual burden of IV during
PM. Due to the nature of the study, although we found negative
correlations between both peripheral and placental blood sCD163
levels and maternal haemoglobin levels for malaria-infected
women, we were not able to establish a causative relationship
between the two parameters.
Apart from scavenging haemoglobin-haptoglobin complexes,
membrane-bound CD163 has also been suggested to bind to
erythroblasts and enhance erythroid proliferation [29]. Because
sCD163 and membrane-bound CD163 levels are inversely
correlated [30], high sCD163 levels may indicate lower membrane
CD163 expression and potentially an impairment in the functions
mediated by this receptor. Whether or not increased sCD163
levels represent impaired membrane-bound CD163 function in
erythropoiesis, leading to lower haemoglobin levels, requires
further investigation.
This study is the first to compare peripheral and placental
sCD163 levels in uninfected women and in women with PM, with
or without IV. Our findings show that increased monocyte/
macrophage activation, characterised by high sCD163 levels, is
associated with lower haemoglobin levels in malaria infection.
Future studies should explore if high sCD163 levels are linked to
decreased erythropoiesis, which then contributes to the pathogen-
esis of malaria-associated anaemia, in pregnant women and
potentially in young children.
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